Anaphase-Promoting Complex Subunit 11 (ANAPC11) Antibody

416€ (200 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Anaphase-Promoting Complex Subunit 11 (ANAPC11) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx432326
tested applications
P-ELISA, WB
Description
ANAPC11 Antibody is a Goat Polyclonal antibody against ANAPC11.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Anaphase-Promoting Complex Subunit 11 (ANAPC11) |
Host | Goat |
Reactivity | Human |
Recommended Dilution | P-ELISA: 1/32000. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Size 1 | 200 µl |
Form | Liquid |
Tested Applications | P-ELISA, WB |
Buffer | Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Gene ID | 51529 |
NCBI Accession | NP_001002244.1, NP_057560.8 |
Alias | ANAPC11,HSPC214,Cyclosome subunit 11 |
Background | Antibody anti-ANAPC11 |
Status | RUO |
Note | Concentration: 0.5 mg/ml - |
Descripción
ANAPC11 is the catalytic RING finger subunit of the Anaphase-Promoting Complex/Cyclosome (APC/C), where it facilitates the ubiquitin transfer activity of the complex. As an E3 ubiquitin ligase, ANAPC11 directly interacts with E2 ubiquitin-conjugating enzymes to catalyze the ubiquitination of cell cycle regulators such as cyclin B and securin, promoting their degradation via the proteasome. This process is critical for initiating anaphase, regulating mitotic exit, and maintaining genomic stability. ANAPC11 is essential for APC/C activity, and its loss or inhibition results in mitotic arrest, aneuploidy, and cell cycle defects. Mutations or dysregulation of ANAPC11 have been associated with cancer progression, as impaired proteolysis of APC/C substrates can lead to uncontrolled proliferation and chromosomal instability. ANAPC11’s catalytic function makes it a central component of APC/C and a potential target for cancer therapies aimed at disrupting mitotic progression in tumor cells.
Related Products

ANAPC11 antibody
Ver Producto
Anaphase-Promoting Complex Subunit 11 (ANAPC11) Antibody
ANAPC11 Antibody is a Rabbit Polyclonal antibody against ANAPC11.
Ver Producto
Anaphase-Promoting Complex Subunit 11 (ANAPC11) Antibody
ANAPC11 Antibody is a Mouse Monoclonal against ANAPC11.
Ver Producto